$Cullinan Therapeutics (CGEM.US)$ NEWS Cullinan Therapeutics...
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1019Followers
63Following
6884Visitors
Follow
104016428 : will that mean that after their presentation on June 1 it might fly high on monday? or when the news is out for ASCO that's the end of the rally